The Johns Hopkins surgeon will helm the agency as layoffs loom and important decisions on treatments for rare and infectious diseases await.
Accelerating The Materials Transition
placeholder text
Copyright @ 2025 ALT LABS
Date:
The Johns Hopkins surgeon will helm the agency as layoffs loom and important decisions on treatments for rare and infectious diseases await.
Copyright @ 2025 ALT LABS